EPZ020411 reduced five-day viability in patient-derived GSC576 and GSC23 glioblastoma stem-like cells. The cellular viability IC50 values printed in Figure 7E were 24.75 μM and 28.91 μM, respectively. These endpoints are distinct from biochemical enzyme-inhibition potency. [1]
Cellular methylation response in GSC576
Cell-based study · Patient-derived glioblastoma stem-like GSC576 cells [1]
EPZ020411 reduced RCC1 R214me2 and H3R2me2 signals with increasing concentration and exposure time. The H4R3me2 signal was comparatively preserved, providing a limited substrate-marker comparison rather than proof of exclusive PRMT6 selectivity.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0, 5, 10, 20 and 50 μM for the concentration series; 20 μM for the time series
- Exposure duration
- 12 h concentration series; 0, 4, 8, 12 and 24 h time series
- Method
- Cell exposure followed by immunoblot analysis
- Reported limits
- Panel A does not specify solvent concentration or blot replicate number; no biochemical IC50 is inferred from these cellular markers.
Methods and source locations
Compound reported in the paper: EPZ020411; Compound label in the paper: EPZ
Findings apply to the reported research reagent and models; no salt conversion or current AdooQ lot validation is inferred.
Figure 7A and caption P153; Results P28; Methods P46, P58; Key Resources Table
RCC1me2 and H3R2me2 immunoblot signals, compared with H4R3me2 and total RCC1/H3: Immunoblot; total RCC1 and histone H3 shown as protein controls. — Figure 7A; Results P28; STAR Methods Immunoblot Analysis (P58)
Five-day viability response in GSC576 and GSC23
Cell-based study · Patient-derived glioblastoma stem-like GSC576 and GSC23 cells [1]
Five-day EPZ020411 exposure decreased cell viability in both GSC models. Figure 7E labels cellular viability IC50 values of 24.75 μM for GSC576 and 28.91 μM for GSC23; these are not biochemical PRMT6 potencies.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0, 0.5, 1, 2, 5, 10, 20, 50 and 100 μM
- Exposure duration
- 5 days
- Method
- Cell viability assay; values normalized to the zero-concentration control in Figure 7E
- Reported limits
- Solvent concentration and IC50 fitting procedure/uncertainty are not specified for Figure 7E. Methods n=4 does not establish four independent biological replicates. Grouped data are mean ± SEM.
Methods and source locations
Compound reported in the paper: EPZ020411; Compound label in the paper: EPZ
Findings apply to the reported research reagent and models; no salt conversion or current AdooQ lot validation is inferred.
Figure 7E; caption P157, P162; Results P28; Methods P46, P55, P77; Key Resources Table
GSC576 viability after 5 days: Figure-labelled IC50; shared viability methods describe CellTiter-Glow 2.0 and n=4 per condition/point. — Figure 7E left; caption P157; Methods P55
GSC23 viability after 5 days: Figure-labelled IC50; shared viability methods describe CellTiter-Glow 2.0 and n=4 per condition/point. — Figure 7E right; caption P157; Methods P55